Address
250 Campus Drive
Marlborough, MA 01752
United States of America (the)
Phone
508 263 2900
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
7063
First IPO Date
March 01, 1990
| Name | Title | Pay | Year Born |
| Stephen MacMillan | Chairman, Chief Executive Officer & President | 3.17M | 1964 |
| Jennifer Schneiders | President of Diagnostic Solutions | 1.11M | 1969 |
| Karleen Oberton | Chief Financial Officer | 1.36M | 1971 |
| Anne Liddy | General Counsel | 1.42M | 1976 |
| Jan Verstreken | Group President of International | 1.44M | 1969 |
| Essex Mitchell | Chief Operating Officer | 1.53M | 1980 |
| Benjamin Cohn | Vice President & Corporate Controller | 0 | N/A |
| Mark Horvath | President of Breast & Skeletal Health Solutions | 0 | 1963 |
| Mark Irving | Vice President & Corporate Secretary | 0 | N/A |
| Paul Malenchini | Chief Information Officer | 0 | N/A |
| Brandon Schnittker | President of GYN Surgical Solutions | 0 | 1985 |
| Michael J. Watts | Corporate Vice President of Investor Relations | 0 | N/A |
| Scott Christensen | Senior Vice President of Global Supply Chain & Regulatory Affairs | 0 | N/A |
| Diana De Walt SPHR | Senior Vice President of Global Human Resources | 0 | 1955 |
| Monica Aguirre Berthelot | Vice President & Chief of Staff | 0 | N/A |
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.